MetaCap

Capstone Cash Flow Statement

NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.44-0.145 (-9.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Capstone free cash flow

In fiscal 2025, Capstone generated -$4.4 million of operating cash flow and spent $122,000 on capital expenditures. That left free cash flow of -$4.5 million, a free-cash-flow margin of -9.7% of revenue. Free cash flow was down 222.5% from the prior year's $3.7 million.

Summary generated from market data by MetaCap's automated system. Methodology

Capstone cash flow statement (annual)

Capstone annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20182018-12-31FY 20172017-12-31FY 20162016-12-31FY 20152015-12-31FY 20142014-12-31FY 20132013-12-31FY 20122012-12-31
Net Income-21.23M-2.56M-3.82M380.00K1.75M-1.61M-2.77M-4.17M-4.11M-4.05M
Net Income growth (YoY)——-1105.00%-78.35%——————
Depreciation & Amortization391.00K310.00K461.00K——179.00K157.00K160.00K173.00K29.00K
Stock-Based Compensation00—15.00K035.00K174.00K53.00K34.00K107.00K
Change in Working Capital-986.00K5.42M235.00K48.00K-52.00K-5.00K130.00K36.00K-194.00K175.00K
Operating Cash Flow-4.41M3.82M1.65M66.00K-1.56M-1.26M-2.15M-4.09M-3.95M-3.37M
Capital Expenditures-122.00K-120.00K-208.00K—————00
Investing Cash Flow-6.91M-120.00K-208.00K000004.00K-206.00K
Share Repurchases————————00
Debt Issued6.25M0————————
Debt Repaid-985.00K-1.00M————————
Financing Cash Flow12.12M-3.74M-1.41M02.14M946.00K1.00M000
Net Change in Cash716.00K-41.00K29.00K66.00K577.00K-313.00K-1.15M-4.09M-3.95M-3.57M
Free Cash Flow-4.53M3.70M1.44M66.00K-1.56M-1.26M-2.15M-4.09M-3.95M-3.37M

This table shows 10 annual periods of Capstone's cash flow statement, from FY 2025 back to FY 2012, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a cash flow statement?

More financial data